Large-Scale Studies Find Effective Strategy to Improve Antibiotic Use in Hospitals Two extensive multi-state studies funded by the National Institutes of Health and led by the University of California, Irvine, Harvard Pilgrim Health Care Institute, and HCA Healthcare have uncovered…
Magic Johnson and The Cigna Group Host Bright Futures Carnival for Kids Affected by SoCal Wildfires In response to the devastation caused by the Southern California wildfires, The Cigna Group and basketball legend Earvin “Magic” Johnson teamed up to bring…
Harrow Expands Access to VEVYE® for Klarity-C Patients at $59 Per Bottle Harrow (Nasdaq: HROW), a leading eyecare pharmaceutical company in North America, has announced the expansion of its VEVYE® Access for All (VAFA) program to include current users of…
A recent survey by Croí, the Heart & Stroke Charity in Ireland, in collaboration with the Global Heart Hub (GHH), has uncovered a worrying lack of awareness about heart attack symptoms among women in Ireland.¹ Despite cardiovascular disease being one…
Five Good Friends, a leading Australian home care provider, has announced a major strategic investment from TPG, a global alternative asset management firm. The partnership will support the company’s continued expansion and innovation within the home care sector. As part…
Fasikl’s NeuroAI™ Wristband Demonstrates Breakthrough Results in Pivotal TRANQUIL Study for Essential Tremor Fasikl, a pioneering neuro-AI company at the forefront of integrating bioelectronic medicine with artificial intelligence, today announced that its landmark TRANQUIL study met its primary endpoint. The…
Teladoc Health Unveils Next-Generation Cardiometabolic Health Program to Combat Chronic Disease Teladoc Health (NYSE: TDOC), a global leader in virtual healthcare, has announced the launch of its next-generation Cardiometabolic Health Program aimed at improving overall population health and preventing the…
QIAGEN Surpasses Q1 2025 Outlook, Raises Full-Year EPS Forecast QIAGEN NV (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced strong preliminary results for the first quarter of 2025, surpassing both its previous guidance for net sales and adjusted earnings per…
Sentynl Therapeutics Unveils First Clinical Evidence Supporting NULIBRY® for Molybdenum Cofactor Deficiency Type A Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly owned by Zydus Lifesciences, Ltd., has announced the publication of groundbreaking clinical data regarding NULIBRY® (fosdenopterin) in the…
Study Finds K Health’s AI Recommendations Match Doctors’ in Accuracy K Health, a leading AI-driven primary care platform, recently revealed exciting results from a novel study demonstrating that its AI-powered Physician Mode closely matched doctors’ clinical decisions in two-thirds of…